Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vadakkuppatu Devasenapathi Ramanathan"'
Autor:
Sanjay Mehendale, Madhuri Thakar, Seema Sahay, Makesh Kumar, Ashwini Shete, Pattabiraman Sathyamurthi, Amita Verma, Swarali Kurle, Aparna Shrotri, Jill Gilmour, Rajat Goyal, Len Dally, Eddy Sayeed, Devika Zachariah, James Ackland, Sonali Kochhar, Josephine H Cox, Jean-Louis Excler, Vasanthapuram Kumaraswami, Ramesh Paranjape, Vadakkuppatu Devasenapathi Ramanathan
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55831 (2013)
STUDY DESIGN: A randomized, double-blind, placebo controlled phase I trial. METHODS: The trial was conducted in 32 HIV-uninfected healthy volunteers to assess the safety and immunogenicity of prime-boost vaccination regimens with either 2 doses of AD
Externí odkaz:
https://doaj.org/article/ffae7051f1b84d1ba64645f461065732
Autor:
Sonali Kochhar, Jayashri Mahalingam, Kelley Loughran, Vadakkuppatu Devasenapathi Ramanathan, Peter Hayes, Makesh Kumar, Eddy Sayeed, Tony Tarragona-Fiol, Angela Lombardo, Paranji Ramaiyengar Narayanan, Suniti Solomon, Patricia E. Fast, Sekhar Chakrabarty, Carl Verlinde, Michelle Seth Smith, Pattabiraman Sathyamoorthy, Dani Vooijs, Dennis Panicali, James Ackland, Jill Gilmour, Gwynneth Stevens, Jean-Louis Excler, Josephine H. Cox, Burc Barin
Publikováno v:
AIDS Research and Human Retroviruses. 25:1107-1116
A recombinant modified vaccinia Ankara virus vaccine candidate (TBC-M4) expressing HIV-1 subtype C env, gag, tat-rev, and nef-RT genes was tested in a randomized, double-blind, dose escalation Phase I trial in 32 HIV-uninfected healthy volunteers who
Autor:
Sanjay Mehendale, Vadakkuppatu Devasenapathi Ramanathan, Makesh Kumar, Seema Sahay, Aylur K. Srikrishnan
Publikováno v:
Human vaccinesimmunotherapeutics. 10(2)
Success of HIV vaccine trials is dependent on infrastructural preparedness of the site, technical expertise of the trial team and strong Socio-political support of the local community. The processes followed and experiences gained while implementing
Autor:
Walter Jaoko, C. Schmidt, Barney S. Graham, Pierre-Alexandre Bart, Nathan Clumeck, Sonali Kochhar, Eva Vets, Arash Bakhtyari, Anwar A. Hoosen, Jan van Lunzen, Burc Barin, Jonathan Weber, Juergen K. Rockstroh, Eftyhia Vardas, Andrew Robinson, Patricia E. Fast, Linda-Gail Bekker, Carol Smith, Soe Than, Elwyn Chomba, Pontiano Kaleebu, Martin Ho, Etienne Karita, Jean-Louis Excler, Vadakkuppatu Devasenapathi Ramanathan, David D. Ho, Barry Peters, Andrew J. McMichael, Alison E. Heald, Michael C. Keefer, Sanjay Mehendale
Publikováno v:
Human vaccinesimmunotherapeutics. 8(5)
Recently, more clinical trials are being conducted in Africa and Asia, therefore, background morbidity in the respective populations is of interest. Between 2000 and 2007, the International AIDS Vaccine Initiative sponsored 19 Phase 1 or 2A preventiv
Autor:
Vadakkuppatu Devasenapathi Ramanathan, Makesh Kumar, Jayashri Mahalingam, Pattabiraman Sathyamoorthy, Paranji Ramaiyengar Narayanan, Suniti Solomon, Dennis Panicali, Sekhar Chakrabarty, Josephine Cox, Eddy Sayeed, James Ackland, Carl Verlinde, Dani Vooijs, Kelley Loughran, Burc Barin, Angela Lombardo, Jill Gilmour, Gwynneth Stevens, Michelle Seth Smith, Tony Tarragona-Fiol
Publikováno v:
AIDS Research & Human Retroviruses; Nov2009, Vol. 25 Issue 11, p1107-1116, 10p